Ankasa Regenerative Therapeutics Garners $8,500,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d3c7640c-d7f7-429a-b5b3-3ba041bb9e0c - Date
6/23/2015 - Company Name
Ankasa Regenerative Therapeutics - Mailing Address
Undisclosed La Jolla, CA 92037 USA - Company Description
Pharmaceutical preparations including reactivated stem cells for organ and tissue re-growth, tissue repair, and healing. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$8,500,000 - Transaction Round
Series A - Proceeds Purposes
Ankasa intends to initially develop a proprietary localized therapy involving WNT3A for spinal fusion surgery patients. - M&A Terms
- Venture Investor
- Venture Investor
